AKCEA THERAPEUTICS INC's ticker is AKCA and the CUSIP is 00972L107. A total of 65 filers reported holding AKCEA THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $795,000 | +44.5% | 43,813 | +9.2% | 0.42% | +60.4% |
| Q2 2020 | $550,000 | +26.1% | 40,123 | +31.6% | 0.26% | +45.3% |
| Q1 2020 | $436,000 | -22.1% | 30,486 | -7.8% | 0.18% | +94.6% |
| Q4 2019 | $560,000 | +227.5% | 33,059 | +197.5% | 0.09% | +170.6% |
| Q3 2019 | $171,000 | -37.8% | 11,111 | -5.3% | 0.03% | -41.4% |
| Q2 2019 | $275,000 | +13.6% | 11,730 | +37.6% | 0.06% | -88.7% |
| Q1 2019 | $242,000 | -16.6% | 8,527 | -11.3% | 0.52% | +930.0% |
| Q4 2018 | $290,000 | -57.4% | 9,610 | -50.5% | 0.05% | -28.6% |
| Q3 2018 | $680,000 | -13.9% | 19,429 | -41.7% | 0.07% | -90.0% |
| Q2 2018 | $790,000 | -21.6% | 33,315 | -15.3% | 0.70% | -20.2% |
| Q1 2018 | $1,008,000 | +221.0% | 39,351 | +117.8% | 0.88% | +122.1% |
| Q4 2017 | $314,000 | – | 18,071 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iguana Healthcare Management, LLC | 100,000 | $1,736,000 | 1.13% |
| BB BIOTECH AG | 1,248,650 | $21,677,000 | 0.61% |
| Virtus ETF Advisers LLC | 18,071 | $314,000 | 0.39% |
| Eventide Asset Management | 420,000 | $7,291,000 | 0.38% |
| Granahan Investment Management | 194,376 | $3,374,000 | 0.26% |
| ALTRINSIC GLOBAL ADVISORS LLC | 150,000 | $2,604,000 | 0.10% |
| Candriam S.C.A. | 114,571 | $1,990,000 | 0.03% |
| ARDSLEY ADVISORY PARTNERS LP | 15,000 | $260,000 | 0.03% |
| Delpha Capital Management, LLC | 1,521 | $26,000 | 0.03% |
| FMR LLC | 9,981,244 | $173,274,000 | 0.02% |